Questions and Answers
Updated 2026
AntihyperlipidemicBBDrugsBlowerBserumBlevelsBofBcholesterolBandBvariousBlipids.BTheyB
areBalsoBcalledBasBlipid-
loweringBagents;BtheseBBdrugsBprovideBeffectiveBtreatmentBforBhyperlipidemiaB(increas
edBlipidBlevelBinBtheBblood).BTheBincidenceBofBcoronaryBarteryBdiseaseB(CAD),BtheBmos
tBcommonBcauseBofBdeathBamongBadults,BisBhigherBinBpeopleBwithBhyperlipidemia.BHi
ghBlevelBofBlipidsBandBtriglycerideBisBassociatedBwithBmetabolicBsyndromeBconsistingBof
BinsulinBresistance,BabdominalBobesity,Bhypertension,BandBproinflammatoryBandBprothro
mboticBstates.
Antihyperlipidemic:BGenericBandBBrandBNames
HereBisBaBtableBofBcommonlyBencounteredBantihyperlipidemicBdrugs,BtheirBgenericBna
mes,BandBbrandBnames:B
Pharmaceuticals&BBiotech
, • BileBAcidBSequestrants
• BcholestyramineB(Questran)
• colesevelamB(Welchol)
• colestipolB(Colestid)
• HMG-CoABReductaseBInhibitors
• atorvastatinB(Lipitor)
• fluvastatinB(Lescol)
• lovastatinB(Mevacor)
• pitavastatinB(Livalo)
• pravastatinB(Pravanchol)
• simvastatinB(Zocor)
• CholesterolBAbsorptionBInhibitor
• ezetimibeB(Zetia)
• Fibrates
• fenofibrateB(TriCor)
• fenofibricBacidB(Tripilix)
• gemfibrozilB(Lopid)
• VitaminBB
• niacinB(Niaspan)
DiseaseBSpotlight:BCoronaryBArteryBDiseaseB(CAD)
• DueBtoBvariousBreasons,BfattyBstreaksBbeginBtoBdevelopBinBtheBendotheliumBofB
coronaryBarteries.BOverBtime,BtheseBfattyBstreaksBdevelopBintoBplaquesB(athero
mas)BandBinjureBtheBliningBofBbloodBvessels.BTheBinflammatoryBreactionBbegins,
BandBitBattractsBwhiteBbloodBcellsBandBplateletsBtoBtheBarea.BTheseBcellsBcollec
tBonBtheBinjuredBvesselsBandBcauseBtheBatheromaBtoBgrowBbigger,BfurtherBnarr
owingBtheBdiameterBofBbloodBvessels,BandBtherefore,BlimitingBtheBbloodBflow.
• TheBinjuryBdecreasesBtheBflexibilityBofBtheBvessels,BrenderingBitBlessBdistensibleB
andBlessBreactiveBtoBneurochemicalBstimuli.BCoronaryBarteriesBareBnowBunableB
toBbalanceBoxygenBdemandBandBbloodBsupply.